# Jade Biosciences, Inc. (JBIO) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Jade Biosciences, Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/JBIO/mda/fy2025/): filed 2026-03-06; accession 0001193125-26-096550 (https://www.sec.gov/Archives/edgar/data/1798749/000119312526096550/ck0001798749-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/JBIO/mda/fy2024/): filed 2025-03-27; accession 0001558370-25-003750 (https://www.sec.gov/Archives/edgar/data/1798749/000155837025003750/avte-20241231x10k.htm)
- [FY 2023 MD&A](/company/JBIO/mda/fy2023/): filed 2024-03-25; accession 0001798749-24-000015 (https://www.sec.gov/Archives/edgar/data/1798749/000179874924000015/tmb-20231231x10k.htm)
- [FY 2022 MD&A](/company/JBIO/mda/fy2022/): filed 2023-03-29; accession 0001798749-23-000015 (https://www.sec.gov/Archives/edgar/data/1798749/000179874923000015/tmb-20221231x10k.htm)
- [FY 2021 MD&A](/company/JBIO/mda/fy2021/): filed 2022-03-30; accession 0001493152-22-008189 (https://www.sec.gov/Archives/edgar/data/1798749/000149315222008189/form10-k.htm)

Back to /company/JBIO/